Millrace Asset Group, Inc. Haemonetics Corp Transaction History

Millrace Asset Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$80.59 - $92.61 $504,976 - $580,294	-6,266 Reduced 32.53%	12,998 $1.11 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $119,051 - $134,812	-1,442 Reduced 6.96%	19,264 $1.73 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $1.67 Million - $1.85 Million	20,706 New	20,706 $1.76 Million
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $838,725 - $1.17 Million	-9,872 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$74.34 - $121.82 $356,311 - $583,883	-4,793 Reduced 32.68%	9,872 $984,000
Q4 2019 Feb 13, 2020	BUY	$114.37 - $129.46 $373,418 - $422,686	3,265 Added 28.64%	14,665 $1.69 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $281,184 - $332,448	2,400 Added 26.67%	11,400 $1.44 Million
Q2 2019 Aug 13, 2019	BUY	$81.74 - $120.34 $735,660 - $1.08 Million	9,000 New	9,000 $1.08 Million

330

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.86B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.